Chrystal Chang, MD
Urology · Philadelphia, PANPI 1568995009
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 38 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 6 manufacturers reported payments, led by Coloplast at 50.6% of the total. 2025 is the largest year on record at $907, 5.1 times the $177 reported in 2022. That places this record below the midpoint for urology clinicians in PA, where the typical reported total is $2,187.
Across 38 payments — averaging $49.07 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Coloplast$944
- Boston Scientific$464
- Procept Biorobotics Corporation$237
- Stryker$131
- ABC Home Medical Supply, Inc.$58
- Ambu Inc.$30
What the payments were for
- Food & beverage$1,865100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Coloplast | 25 | $944 |
| Boston Scientific | 6 | $464 |
| Procept Biorobotics Corporation | 3 | $237 |
| Stryker | 1 | $131 |
| ABC Home Medical Supply, Inc. | 2 | $58 |
| Ambu Inc. | 1 | $30 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- GENERAL ERECTILE DYSFUNCTION$275
- TITAN$250
- AquaBeam Robotic System$150
- 1788$131
- Coloplast TFL Drive$119
How this compares
$1,865 in reported general payments places this provider in the 45th percentile of 596 urology providers in Pennsylvania.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Trospium Chloride | 43 | $2,217 |
| Tamsulosin Hcl | 96 | $1,118 |
| Alfuzosin Hcl ErAlfuzosin Hcl | 23 | $417 |
| Finasteride | 18 | $270 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 20 | $65 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 11 | $51 |
| Levofloxacin | 12 | $25 |
Paid to pharmacies, not to this prescriber.
Other urology in Philadelphia
- Demetrius BagleyPhiladelphia$739K
- Daniel EunPhiladelphia$226K
- Leonard GomellaPhiladelphia$190K
- Phillip GinsbergPhiladelphia$145K
- Edouard TrabulsiPhiladelphia$137K
- Siobhan HartiganPhiladelphia$121K
- Paul ChungPhiladelphia$120K
- William JaffePhiladelphia$119K
- Robert UzzoPhiladelphia$111K
- Jay SimhanPhiladelphia$110K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.